Ray Dalio's position in Abbvie is currently worth $101 Million. That's 0.56% of their equity portfolio (38th largest holding). The first Abbvie trade was made in Q4 2020. Since then Ray Dalio bought shares eight more times and sold shares on four occasions. The stake costed the investor $88.6 Million, netting the investor a gain of 14% so far.